Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...
A large-scale study has identified dozens of blood proteins linked to prostate cancer risk, some shared across populations, ...
A large national and international study has identified dozens of blood proteins linked to prostate cancer risk, some shared across populations, some unique to specific groups. Published in Nature ...
SAN DIEGO—Genetic analyses suggest that prostate cancer is distinctly different in African-American men compared with European-American men, according to researchers at the National Cancer Institute ...
A number of recently developed and promising approaches to antitumoral immunotherapy are being investigated as potential treatments for advanced prostate cancer. These approaches largely revolve ...
– 32nd Annual Scientific Retreat brought together 600+ prostate cancer researchers and leaders to spotlight breakthrough discoveries and advance cutting-edge science – – PCF continues to be the ...
Today, a patient diagnosed with advanced prostate cancer has options. Doctors can offer a suite of androgen-suppressing drugs to extend his life. There are genetic tests that can show whether he’s a ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results